1/3

FIEO Registered Export Ready

Voglibose, Glimepiride &Metformin HCl (SR) Tablets

Name: Voglibose, Glimepiride &Metformin HCl (SR) Tablets
Brand: indiglobal exports
SKU: 8520221
Availability: InStoreOnly

Sold by indiglobal exports · Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Blister/Strip Packs with export-grade material

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for indiglobal exports.

Compliance & Certifications

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Panchkula Dispatch on request FIEO member

indiglobal exports

Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

We are a distinguished merchant trading and export company, specializing in the international supply of premium-quality products across various sectors. Our portfolio includes pharmaceuticals, marketed under a neutral code, as well as millets, mango pulp, compounded animal and livestock feed, and orthopaedic appliances. We take great pride in our meticulous product selection and procurement processes, consistently adhering to the highest standards of quality assurance to ensure the delivery of superior goods to our clients.

Registered address: Chandigarh, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Medical Equipment & Supplies.

View profile All products

Established

2024

Employees

1–10

GST

06EOGPS3248L1ZF

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Apr 2024

Turnover

2500001 - 10000000.

Incorporation Type

On request

Verified Seller IEC Certificate GST Certificate UDYAM Registration Certificate

Product details

What are the specifications of this product?

Overview

Voglibose, Glimepiride & Metformin HCl (SR) Tablets is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations. Features: Used in the management of diabetes conditions Precise dosage form and active pharmaceutical ingredients Suitable for international pharmaceutical markets Manufactured in GMP-compliant facilities Reliable therapeutic performance Attributes: Category: Diabetes Formulation: Tablet Packaging: Export-grade blister or strip packs Shelf Life: As per regulatory standards Manufacturer: IndiGlobal Exports

Product Description

Product Overview

Voglibose, Glimepiride & Metformin HCl (SR) Tablets is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.

Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.

Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.

Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.

Description provided by indiglobal exports.

Specifications

Active Pharmaceutical Ingredients	Voglibose, Glimepiride, Metformin Hydrochloride (SR)
Pharmaceutical Category	Antidiabetic Medication
Manufacturer	IndiGlobal Exports
Formulation	Tablet
Packaging	Blister/Strip Packs with export-grade material
Storage Conditions	Store in a cool, dry place away from direct sunlight
Regulatory Compliance	Complies with international healthcare regulations
Intended Use	Clinical management of diabetes mellitus type 2
Mode of Action	Combination therapy targeting postprandial and fasting blood glucose
Shelf Life	Typically 24 months (subject to regulatory approval)

Use cases

Category	Pharmaceuticals > Anti-diabetic Drugs > Combination Tablets
Primary application	Wholesale, distribution, and international sourcing
Brand	indiglobal exports
Product type	Product

Logistics & handling

Lead time	On request
Packaging	Blister/Strip Packs with export-grade material
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Voglibose, Glimepiride &Metformin HCl (SR) Tablets. Answers compiled from verified sellers' commercial terms and platform data.

Q: What advantage does the sustained-release Metformin component provide in this formulation?

A: The sustained-release Metformin component improves bioavailability and prolongs therapeutic action, allowing for reduced dosing frequency and minimized gastrointestinal side effects compared to immediate-release formulations.

Q: Is this tablet formulation suitable for export to regulated international markets?

A: Yes, the tablets are manufactured under WHO-GMP facilities and comply with IP/USP pharmacopoeial standards, making them suitable for regulated and semi-regulated international markets.

Q: What packaging options are available for bulk export?

A: The tablets are available in export-grade blister or strip packs designed to ensure product stability and convenience for bulk shipping and institutional supply.

Q: Can these tablets be used for both hospital and retail pharmacy settings?

A: Yes, the formulation is designed for use in both hospital inpatient care and retail pharmacy settings, providing flexible options for diabetes management.

Q: Which types of diabetes patients are targeted by this pharmaceutical product?

A: This formulation is intended primarily for the management of type 2 diabetes mellitus patients requiring combination therapy for effective glycemic control.

Question not answered? Ask sellers directly — typical response within 4 hours.